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Abstract
Introduction: We compared the predictive ability of the Mini-Mental State Examination (MMSE) and the Montreal
Cognitive Assessment (MoCA) to diagnose dementia in a community-based study.
Methods: A total of 276 people aged 60 years or older were enrolled. All of the participants were administered
face-to-face interview questionnaires and MoCA and MMSE examinations. The receiver operating characteristic
curve method and area under curve were performed to assess the predictive ability for diagnosing dementia.
Results: The 276 participants had a mean age of 67.9 ± 6.1 years and mean education duration of 11.4 ± 4.0 years.
In general, the MoCA yielded higher AUCs (0.891) with favorable sensitivity (78 %) and excellent specificity (94 %)
compared with the MMSE in differentiating the participants with and without dementia in either the total sample
or all subgroups.
Conclusion: Our study determined a higher predictive ability in the MoCA than in the MMSE for diagnosing dementia
according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria in a community-based
sample with a broader range of education level.
Introduction
The population is rapidly aging worldwide [1, 2]. The
prevalence of dementia increases rapidly with age and
leads to a burden on public health [3–7]. Detecting mod-
erate cognitive dysfunction early could decrease the risk
factors associated with vascular events, resulting in the
prevention of dementia [8].
Cognitive function can be measured using several in-
struments, such as the Clinical Dementia Rating Scale,
the Global Deterioration Scale, and the Mini-Mental
State Examination (MMSE) [9–12]. The MMSE has been
broadly applied to assess cognitive function [13–16], but
it is insufficient and highly influenced by education [17].
The Montreal Cognitive Assessment (MoCA) is a new
instrument for detecting mild cognitive dysfunction with
superior sensitivity and can be completed in 10 minutes
by clinicians [18].
Numerous studies have validated the cognitive screen-
ing ability between the MoCA and MMSE, showing that
the MoCA is a more useful screening instrument than the
MMSE for detecting dementia [19–24]. Some researchers,
however, have indicated that the MoCA was not superior
to the MMSE for assessing patients with mild cognitive
impairment (MCI) [25, 26]. In some hospital-based re-
search, the gold standards were the neuropsychological
tests [19–23]. Some studies demonstrated their findings in
the community, but did not choose a gold standard of the
Diagnostic and Statistical Manual of Mental Disorders,
Fourth Edition (DSM-IV) [24]. To decide which is best
(i.e., diagnosed by physicians according to DSM-IV criteria
and community-based samples) is difficult. Thus, the con-
clusions reported to date remain obscure.
The purpose of this study was to compare the screening
ability of the MoCA with that of the MMSE for detecting
dementia in a community-based population. In addition,
we performed an analysis of subgroups stratified according
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to age, sex, and education level to examine the predictive
ability of the MoCA for diagnosing dementia.
Methods
Study population
The participants were randomly sampled in 2007–2008
from among all of the residents aged 60 years or older in a
community (n = 448) that neighbored a teaching hospital.
They were invited to participate in a community-based
prospective cohort study investigating the cardiovascular
and cerebrovascular risk factors in the general population
[27, 28]. The participants were invited again after 3 years
to undergo follow-up examinations to measure the neuro-
logical assessments from 2011 to 2013. Those who de-
clined to participate in the follow-up study were excluded.
A total of 276 remaining individuals were enrolled in this
study for the analysis.
Instruments
The MoCA scale is a cognitive screening test with a high
level of interrater reliability and internal consistency for
detecting dementia. It can be administered in approxi-
mately 10 minutes [18, 20, 22]. Eight subitems were used
to measure cognitive function: (1) visuospatial/executive
function (an alternation task adapted from the Trail
Making Test Part B task, a clock-drawing task, and a
three-dimensional cube copy), (2) naming (a three-item
confrontation naming task with low-familiarity animals),
(3) memory (the short-term memory recall task with two
learning trials of five nouns, no points), (4) attention (a sus-
tained attention task with target detection using tapping, a
serial subtraction task, and digits forward and backward),
(5) language (repetition of two syntactically complex sen-
tences and a phonemic fluency task), (6) abstraction (a two-
item verbal abstraction task), (7) delayed recall (5-minute
delayed memory assessment of the short-term memory re-
call task for five nouns), and (8) orientation (evaluated time
and place) [18]. For the participants with less than 12 years
of education, the final score was the MoCA plus 1 point.
The interrater intraclass correlation coefficient of MoCA in
this study was 0.852, which showed high reliability.
The MMSE test has adequate interrater reliability and
internal consistency in predicting dementia. It is used to
screen for cognitive impairment and dementia [12].
Clinical evaluations
The participants were recruited by performing two-stage
screening. During the first stage in 2007–2008, a survey
with a standardized and structured questionnaire was con-
ducted by well-trained interviewers to obtain demographic
information. Age (as a continuous variable and divided
into three categories: 60–69, 70–79, and ≥80 years), sex,
and duration of education (as continuous variable and di-
vided into three categories: ≤6, 7–12, and >12 years) were
evaluated. An approximately 2-year follow-up survey was
conducted to collect the results from a clinical examin-
ation performed by neurologists. From 2011 to 2013, all of
the participants were administered face-to-face interview
questionnaires and the MoCA and MMSE examinations
in approximately 30 minutes in clinical practice. The clin-
ical diagnosis of dementia was based on the judgment of a
single neurologist. The neurologist made the diagnosis on
the basis of interviews of participants and their caregivers
(usually the participant’s spouse). The participants’ previous
function was evaluated on the basis of caregivers’ and par-
ticipants’ statements. Details were collected regarding cog-
nitive function, such as memory, communication, motor
function, recognition or identification of objects, and ex-
ecutive function. Daily activities, including shopping,
housekeeping, cocking, doing laundry, and using transpor-
tation, were also examined. Next, the office-based neuro-
logical examination was performed. If the participant had
memory impairment and other domains of cognitive im-
pairment based on the DSM-IV diagnostic criteria for Alz-
heimer’s disease, dementia was diagnosed. The laboratory
examination included a blood test, thyroid function exam-
ination, and liver and renal function. Brain computed tom-
ography was performed to exclude structural lesions for the
possibility of secondary dementia. The neurologist was
blinded to participants’ cognitive function state.
Statistical analysis
Statistical analysis was performed using SAS version 9.2
software (SAS Institute, Cary, NC, USA). The descrip-
tive results of continuous variables were expressed as
mean ± standard deviation. Baseline demographic status
and MoCA scores were compared by using a t test or one-
way analysis of variance for continuous variables and the χ2
test for categorical variables. A P value less than 0.05 was
considered statistically significant.
A receiver operating characteristic (ROC) curve was con-
structed to establish MoCA cutoff points for all of the par-
ticipants and subgroups. The area under the curve (AUC)
was calculated for each of the ROC curves with a 95 %
confidence interval. The cutoff scores were derived from
the ROC coordinate points, at which both sensitivity and
specificity were calculated using Youden’s J statistic (You-
den’s index).
All participants provided written informed consent be-
fore study entry. This study was also evaluated and ap-
proved by the institutional review board of Taipei Medical
University and Shin Kong Wu Ho-Su Memorial Hospital.
Results
Among the 276 participants, 16 (5.8 %) were diagnosed
with dementia and 260 (94.2 %) were diagnosed with nor-
mal cognitive function. The demographic variables and
MoCA scores of all 276 participants and the subgroups
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were stratified according to sex (Table 1). Compared with
the women, the men had a significantly higher duration of
education and were older. The MoCA scores for visuo-
spatial function, naming, and abstraction of the men were
significantly higher than those of the women. However, no
differences in total score by sex were observed.
As shown in Table 2, the MoCA scale scores were strati-
fied according to education level and age. Regarding edu-
cation level, significant differences were observed between
three groups in total scores and the scores for eight
subitems.
ROC analysis results for dementia are shown in Table 3
and Fig. 1. For all of the 276 participants, the MoCA
yielded greater AUCs than the MMSE to differentiate be-
tween participants with and without dementia (0.8913 vs
0.6976). In addition, the MoCA in all subgroups achieved
higher AUCs than did the MMSE for dementia. Because
no dementia patients were in the high-education group,
AUCs could not be calculated.
We determined the cutoff points of the MoCA scale
for all participants. The cutoff score on the MoCA was
23.5, demonstrating favorable sensitivity (78 %) and spe-
cificity (94 %).
Discussion
We show that the MoCA had superior predictive ability
for detecting dementia. The sensitivity of 0.78 and speci-
ficity of 0.94 of MoCA were higher than the values for
the MMSE. For the subgroup analysis, the findings were
essentially the same for the women, younger participants
(i.e., aged 60–69 years), and those with a low education
level. The optimal cutoff score on the MoCA was 23.5,
with a high AUC of 0.89.
In most previous studies [19–24], researchers have also
reported that the MoCA appeared to be more useful as a
cognitive screening tool than the MMSE. However, the in-
vestigators in these studies have not used the same criter-
ion of cognitive dysfunction. The study samples may have
been recruited primarily from a clinic and not from the
general population, as in our present study [19–23]. In
only one study did researchers recruit community-based
participants, but the diagnostic criteria were not based on
DSM-IV [24]. Other researchers have reported that the
MoCA was not more effective than the MMSE in asses-
sing dementia [25, 26]. The inconsistent findings might be
due to the sample location, different participant ages, and
varying criteria for diagnosing cognitive function. Distinct
sample distributions in different studies make comparing
findings difficult.
The cutoff score on the MoCA analyzed for our partici-
pants was 23.5, which is consistent with previous studies
that indicated a high sensitivity and specificity for identify-
ing Alzheimer’s disease and dementia, with optimal cutoff
scores ranging from 22 to 26 [19–24]. In some studies, re-
searchers have presented a cutoff point of 23 for the
MoCA, similar to our findings, with the average education
Table 1 Comparison of demographic variables and the MoCA scale stratified by gender
Total Gender
Male Female
Variables N = 276 N = 136 N = 140 P value a
Age (years ± SD) 67.93 ± 6.06 68.93 ± 6.30 66.95 ± 5.68 0.0064**
Male (%) 136 (49.28%)
Education (years ± SD) 11.38 ± 4.01 12.39 ± 3.98 10.40 ± 3.82 < 0.0001***
Total Score 25.33 ± 3.44 25.51 ± 3.24 25.16 ± 3.64 0.4088
Visuospatial 3.97 ± 1.03 4.15 ± 0.97 3.81 ± 1.06 0.0057**
Naming 2.76 ± 0.57 2.90 ± 0.35 2.63 ± 0.69 < 0.0001***
Memory1 4.03 ± 1.06 3.98 ± 1.07 4.08 ± 1.04 0.4418
Memory2 4.61 ± 0.81 4.55 ± 0.84 4.67 ± 0.77 0.3364
Attention1 1.85 ± 0.40 1.85 ± 0.36 1.84 ± 0.44 0.8334
Attention2 0.95 ± 0.22 0.94 ± 0.24 0.96 ± 0.20 0.5473
Attention3 2.85 ± 0.42 2.85 ± 0.41 2.84 ± 0.44 0.8441
Language1 1.25 ± 0.73 1.24 ± 0.73 1.26 ± 0.73 0.7415
Language2 0.80 ± 0.40 0.76 ± 0.43 0.84 ± 0.37 0.1025
Abstraction 1.30 ± 0.76 1.43 ± 0.75 1.19 ± 0.76 0.0086**
Delayed Recall 3.04 ± 1.71 2.98 ± 1.73 3.11 ± 1.70 0.5321
Orientation 5.95 ± 0.24 5.94 ± 0.24 5.95 ± 0.25 0.7632
MoCA Montreal Cognitive Assessment, SD standard deviation
*: P < 0.05; **: P < 0.01; ***: P < 0.0001
a. Tested by two-sample t test
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Table 2 Comparison of demographic variables and the MoCA scale stratified by education level and age
Education Age (years)
Low Middle High 60–69 70–79 ≧ 80
Variables N = 61 N = 118 N = 97 P value a P trend N = 171 N = 91 N = 14 P value
a P trend
Age (years ± SD) 67.77 ± 5.63 68.58 ± 6.59 67.23 ± 5.62 0.2572 0.4378 63.96 ± 2.91a 73.27 ± 2.79b 81.57 ± 2.44c < 0.0001*** < 0.0001***
Male (%) 20 (32.79%) 53 (44.92%) 63 (64.95%) 0.0002** 77 (45.03%) 48 (52.75%) 11 (78.57%) 0.0392*
Education (years ± SD) 5.66 ± 1.35a 10.74 ± 1.53b 15.76 ± 1.21c < 0.0001*** < 0.0001*** 11.52 ± 4.10 11.16 ± 3.96 11.00 ± 3.33 0.7403 0.4450
Total Score 23.39 ± 3.87a 25.28 ± 3.38b 26.62 ± 2.58c < 0.0001*** < 0.0001*** 25.94 ± 3.09a 24.62 ± 3.66b 22.64 ± 4.09b 0.0001** < 0.0001***
Visuospatial 3.38 ± 1.08a 3.93 ± 1.02b 4.40 ± 0.77c < 0.0001*** < 0.0001*** 4.03 ± 1.00 3.95 ± 1.02 3.50 ± 1.34 0.1696 0.1116
Naming 2.59 ± 0.78a 2.74 ± 0.55 2.90 ± 0.37b 0.0032** 0.0007** 2.80 ± 0.52 2.70 ± 0.62 2.64 ± 0.74 0.3096 0.1281
Memory1 3.62 ± 1.22a 4.07 ± 1.04b 4.25 ± 0.89b 0.0022** 0.0008** 4.15 ± 1.02 3.86 ± 1.06 3.50 ± 1.31 0.0269* 0.0072**
Memory2 4.41 ± 0.95a 4.57 ± 0.76 4.80 ± 0.73b 0.0405* 0.0117* 4.64 ± 0.80a 4.64 ± 0.67a 4.10 ± 1.37b 0.1198 0.1813
Attention1 1.80 ± 0.44 1.82 ± 0.45 1.91 ± 0.29 0.1816 0.0855 1.88 ± 0.36a 1.86 ± 0.38a 1.43 ± 0.65b 0.0002** 0.0050*
Attention2 0.92 ± 0.28 0.95 ± 0.22 0.97 ± 0.17 0.3658 0.1602 0.96 ± 0.20a 0.95 ± 0.23 0.86 ± 0.36 0.2435 0.1686
Attention3 2.80 ± 0.48 2.84 ± 0.45 2.89 ± 0.35 0.4668 0.2186 2.87 ± 0.38 2.79 ± 0.51 2.93 ± 0.27 0.2670 0.4875
Language1 0.92 ± 0.78a 1.18 ± 0.74a 1.55 ± 0.56b < 0.0001*** < 0.0001*** 1.35 ± 0.68a 1.15 ± 0.80 0.71 ± 0.47b 0.0022** 0.0008**
Language2 0.84 ± 0.37 0.75 ± 0.43 0.85 ± 0.36 0.1927 0.6787 0.86 ± 0.35a 0.75 ± 0.44 0.50 ± 0.52b 0.0011** 0.0004**
Abstraction 0.79 ± 0.76a 1.26 ± 0.76b 1.68 ± 0.55c < 0.0001*** < 0.0001*** 1.40 ± 0.72a 1.11 ± 0.82b 1.36 ± 0.74 0.0115* 0.0297*
Delayed Recall 2.49 ± 1.76a 2.94 ± 1.67a 3.52 ± 1.63b 0.0008** 0.0002** 3.27 ± 1.63a 2.73 ± 1.81b 2.35 ± 1.74 0.0149* 0.0039**
Orientation 5.89 ± 0.37 5.96 ± 0.20 5.97 ± 0.17 0.0828 0.0472* 5.95 ± 0.21a 5.97 ± 0.18a 5.71 ± 0.61b 0.0010* 0.0560
MoCA Montreal Cognitive Assessment, SD standard deviation
*: P < 0.05 ; **: P < 0.01 ; ***: P < 0.0001















Table 3 AUC and cut-off points of the MoCA, MMSE stratified by gender, education level, and age
MoCA MMSE
Area 95% CI Optimal cut-off Sensitivity Specificity Area 95% CI Optimal cut-off Sensitivity Specificity
Total 0.8913 0.83–0.96 23.5 0.78 0.94 0.6976 0.56–0.83 28.5 0.38 0.92
Gender
Men 0.8882 0.79–0.98 22.5 0.84 0.88 0.6717 0.51–0.84 28.5 0.35 1.00
Women 0.8984 0.81–0.99 23.5 0.76 1.00 0.7317 0.50–0.96 25.5 0.77 0.67
Age (years)
60–69 0.9625 0.90–1.00 23.5 0.84 1.00 0.8925 0.83–0.96 25.5 0.85 1.00
70–79 0.8244 0.71–0.94 23.5 0.67 0.88 0.6456 0.44–0.85 24.5 0.87 0.38
≧ 80 0.8788 0.69–1.00 22.0 0.73 1.00 0.5758 0.19–0.96 28.5 0.27 1.00
Education level
Low 0.9709 0.91–1.00 20.5 0.89 1.00 0.7965 0.60–0.99 24.5 0.79 0.75
Middle 0.8465 0.75–0.94 23.5 0.80 0.90 0.6290 0.45–0.81 28.5 0.41 0.88
















duration ranging from 9.8 to 14.4 years [19, 22, 24]. This
means that the MoCA score was not significantly influ-
enced by education level within this range. Furthermore,
our results are similar to those reported by Tsai et al., who
studied a Taiwanese population [22]. They reported that
the optimal cutoff point for dementia was 23 or 24, with a
sensitivity of 92 % and specificity of 78 %. These similar
results may reflect that both sample populations were
close to coherent and the criteria for identifying cognitive
impairment were remarkably similar.
In the subgroup analysis, age, sex, and education level
were stratified according to the aforementioned definition.
The results were largely unchanged. Consistent with pre-
vious studies [29, 30], the female participants exhibited
slightly higher AUCs. As expected, this suggests that
women received shorter education than men did, according
Fig. 1 Receiver operating characteristic (ROC) curves constructed after assessing dementia with the Montreal Cognitive Assessment (MoCA) and
the Mini-Mental State Examination (MMSE). The ROC curves were tested in the total sample and in stratified subgroups according to the age, sex,
and education level. a Total, b men, c women, d 60 men, ted and e ages 70–79 years, f age ≥80 years, g low education, and h middle education
groups.
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to their cultural background in China [31]. High MoCA
scores were observed for the younger participants and
those with a high education level. This result was similar to
outcomes in a Chinese-American study [31]. Education and
age could influence the MoCA score.
The results for the eight subitems of the MoCA differed
in the subgroups of age, sex, and education level. Nonethe-
less, few studies have investigated the association between
subgroups and eight subitems [32, 33]. High scores for
visuospatial function, naming, and abstraction among the
men were determined in our study. However, this result
was not consistent with findings in an Italian study, in
which researchers showed that sex influenced the attention
and memory domains [32]. The culture difference may ex-
plain the disparity in the contrasting results. Our findings
regarding the subitem scores of the older participants are
comparable to the Italian data, except for the domains of
attention and orientation [32]. Another Taiwanese study,
published in 2012, showed that the subitem scores on the
MoCA were influenced by education level. Participants
with 0–6 years of education had the lowest scores for
visuospatial and executive function, abstraction, orienta-
tion, and naming domains [33].
The strengths of the present study are the use of a
community-based population, DSM-IV criteria for diagnosing
dementia based on clinical assessments, and analysis of
subgroups stratified according to age, sex, and education
level. Previous hospital-based sample studies [19–23] led to
selection bias, and thus their results cannot be extrapolated
to the general population. Dementia was diagnosed by a
neurologist according to DSM-IV criteria, and the accuracy
was high. Other studies have applied questionnaires to
define dementia. Subgroup analysis was also performed in
the present study. The results were similar and showed that
the MoCA was a stable instrument for assessing dementia.
The prevalence of dementia in our study was comparable
(5.8 %) to that in other studies (5.7 % and 5.4 %) done in
Taiwan [34, 35]. The representativeness of this community-
based sample is supported.
Several limitations should be carefully addressed. First,
the participants were recruited from one district in Taiwan.
The representativeness was limited and might not be
generalizable to other regions. However, the participants
were randomly selected in proportions that were consistent
within the population. The discrepancy was then mini-
mized. Second, a substantial proportion of the initially
enrolled participants withdrew from the study during the
follow-up period. Nevertheless, the difference in demo-
graphic distribution between the analyzed sample and those
who withdrew was not significant. Third, there were no
dementia events in the high education level group, which
might have influenced the MoCA cutoff score. Nonetheless,
it was similar to that in another Taiwanese study with a
MoCA cutoff score of 23/24. Finally, MCI was not assessed
in the present study. Diagnoses of MCI are very heteroge-
neous due to different diagnostic criteria. On the basis of
the National Institute on Aging/Alzheimer’s Association
core clinical criteria for MCI [36], the diagnosis of MCI re-
quires detailed episodic memory measures, such as the Free
and Cued Selective Reminding Test or the Logical Memory
subtest of the Wechsler Memory Scale. Our study did not
include this measurement. A future study will be focused
on the relationship between the MoCA score and partici-
pants with MCI.
Conclusions
This study demonstrates that the MoCA had a superior
capability to detect dementia compared with the MMSE
in a community-based sample with a broad range of edu-
cation levels. Dementia was diagnosed by a physician ac-
cording to DSM-IV criteria. Our results not only suggest
that the MoCA is a useful screening tool but also explain
the different features in the stratified groups. Future stud-
ies should be focused on early detection and treatment of
cognitive dysfunction in clinical practice.
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